Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 119 entries
Sorted by: Best Match Show Resources per page
Management of refractory ascites in cirrhosis: Are we out of date?.

World journal of hepatology

Annamalai A, Wisdom L, Herada M, Nourredin M, Ayoub W, Sundaram V, Klein A, Nissen N.
PMID: 27729954
World J Hepatol. 2016 Oct 08;8(28):1182-1193. doi: 10.4254/wjh.v8.i28.1182.

Cirrhosis is a major cause of morbidity and mortality worldwide with liver transplantations as it only possible cure. In the face of a significant organ shortage many patients die waiting. A major complication of cirrhosis is the development of...

Cite
Annamalai A, Wisdom L, Herada M, et al. Management of refractory ascites in cirrhosis: Are we out of date?. World J Hepatol. 2016;8(28):1182-1193doi: 10.4254/wjh.v8.i28.1182.
Annamalai, A., Wisdom, L., Herada, M., Nourredin, M., Ayoub, W., Sundaram, V., Klein, A., & Nissen, N. (2016). Management of refractory ascites in cirrhosis: Are we out of date?. World journal of hepatology, 8(28), 1182-1193. https://doi.org/10.4254/wjh.v8.i28.1182
Annamalai, Alagappan, et al. "Management of refractory ascites in cirrhosis: Are we out of date?." World journal of hepatology vol. 8,28 (2016): 1182-1193. doi: https://doi.org/10.4254/wjh.v8.i28.1182
Annamalai A, Wisdom L, Herada M, Nourredin M, Ayoub W, Sundaram V, Klein A, Nissen N. Management of refractory ascites in cirrhosis: Are we out of date?. World J Hepatol. 2016 Oct 08;8(28):1182-1193. doi: 10.4254/wjh.v8.i28.1182. PMID: 27729954; PMCID: PMC5055587.
Copy Download .nbib Format: NLM
Lessons from the infuse trials: do we need a classification of bias in scientific publications and editorials?.

Current reviews in musculoskeletal medicine

Hashmi S, Noureldin M, Khan SN.
PMID: 24878967
Curr Rev Musculoskelet Med. 2014 Sep;7(3):193-9. doi: 10.1007/s12178-014-9223-1.

The original 13 Food and Drug Administration industry-sponsored recombinant human bone morphogenetic protein-2 (rhBMP-2) trials investigating its use in spinal fusion all reported no associated adverse events. However, subsequent series of studies began reporting complication rates that were much...

Cite
Hashmi S, Noureldin M, Khan SN. Lessons from the infuse trials: do we need a classification of bias in scientific publications and editorials?. Curr Rev Musculoskelet Med. 2014;7(3):193-9doi: 10.1007/s12178-014-9223-1.
Hashmi, S., Noureldin, M., & Khan, S. N. (2014). Lessons from the infuse trials: do we need a classification of bias in scientific publications and editorials?. Current reviews in musculoskeletal medicine, 7(3), 193-9. https://doi.org/10.1007/s12178-014-9223-1
Hashmi, Sohaib, et al. "Lessons from the infuse trials: do we need a classification of bias in scientific publications and editorials?." Current reviews in musculoskeletal medicine vol. 7,3 (2014): 193-9. doi: https://doi.org/10.1007/s12178-014-9223-1
Hashmi S, Noureldin M, Khan SN. Lessons from the infuse trials: do we need a classification of bias in scientific publications and editorials?. Curr Rev Musculoskelet Med. 2014 Sep;7(3):193-9. doi: 10.1007/s12178-014-9223-1. PMID: 24878967; PMCID: PMC4596163.
Copy Download .nbib Format: NLM
[Paravertebral masses].

La Revue de medecine interne

Ziadi T, En-Nafaa I, Africha T, Eddou H, Hammoune N, Nourredine A, Drissi M, Hommadi A.
PMID: 27241075
Rev Med Interne. 2017 Sep;38(9):638-639. doi: 10.1016/j.revmed.2016.04.009. Epub 2016 May 27.

No abstract available.

Cite
Ziadi T, En-Nafaa I, Africha T, et al. Des masses paravertébrales. [Paravertebral masses]. Rev Med Interne. 2016;38(9):638-639doi: 10.1016/j.revmed.2016.04.009.
Ziadi, T., En-Nafaa, I., Africha, T., Eddou, H., Hammoune, N., Nourredine, A., Drissi, M., & Hommadi, A. (2017). Des masses paravertébrales. [Paravertebral masses]. La Revue de medecine interne, 38(9), 638-639. https://doi.org/10.1016/j.revmed.2016.04.009
Ziadi, T, et al. "Des masses paravertébrales." [Paravertebral masses]. La Revue de medecine interne vol. 38,9 (2017): 638-639. doi: https://doi.org/10.1016/j.revmed.2016.04.009
Ziadi T, En-Nafaa I, Africha T, Eddou H, Hammoune N, Nourredine A, Drissi M, Hommadi A. Des masses paravertébrales. [Paravertebral masses]. Rev Med Interne. 2017 Sep;38(9):638-639. doi: 10.1016/j.revmed.2016.04.009. Epub 2016 May 27. French. PMID: 27241075.
Copy Download .nbib Format: NLM
Primary nasopharyngeal Hodgkin's disease: case report and literature review.

Journal of medical case reports

Bensouda Y, El Hassani K, Ismaili N, Lalya I, Boutayeb S, Benjaafar N, El Gueddari BK, Errihani H.
PMID: 20420699
J Med Case Rep. 2010 Apr 26;4:116. doi: 10.1186/1752-1947-4-116.

INTRODUCTION: Primary Hodgkin's disease of the nasopharynx is a rare and uncommon event. It has a relatively favorable prognosis and represents less than 1% of all documented cases of Hodgkin's disease.CASE PRESENTATION: A 40-year-old Arabic man presented initially with...

Cite
Bensouda Y, El Hassani K, Ismaili N, et al. Primary nasopharyngeal Hodgkin's disease: case report and literature review. J Med Case Rep. 2010;4:116doi: 10.1186/1752-1947-4-116.
Bensouda, Y., El Hassani, K., Ismaili, N., Lalya, I., Boutayeb, S., Benjaafar, N., El Gueddari, B. K., & Errihani, H. (2010). Primary nasopharyngeal Hodgkin's disease: case report and literature review. Journal of medical case reports, 4116. https://doi.org/10.1186/1752-1947-4-116
Bensouda, Youssef, et al. "Primary nasopharyngeal Hodgkin's disease: case report and literature review." Journal of medical case reports vol. 4 (2010): 116. doi: https://doi.org/10.1186/1752-1947-4-116
Bensouda Y, El Hassani K, Ismaili N, Lalya I, Boutayeb S, Benjaafar N, El Gueddari BK, Errihani H. Primary nasopharyngeal Hodgkin's disease: case report and literature review. J Med Case Rep. 2010 Apr 26;4:116. doi: 10.1186/1752-1947-4-116. PMID: 20420699; PMCID: PMC2886079.
Copy Download .nbib Format: NLM
4-Methyl-anilinium nitrate.

Acta crystallographica. Section E, Structure reports online

Benali-Cherif N, Boussekine H, Boutobba Z, Dadda N.
PMID: 21578339
Acta Crystallogr Sect E Struct Rep Online. 2009 Oct 17;65:o2744. doi: 10.1107/S1600536809041488.

The asymmetric unit of the title compound, C(7)H(10)N(+)·NO(3) (-), consists of a 4-methyl-anilinium cation protonated at the amino group and a nitrate anion. In the crystal, anions and cations are linked through N-H⋯O and N-H⋯(O,O) hydrogen bonds, buiding a...

Cite
Benali-Cherif N, Boussekine H, Boutobba Z, et al. 4-Methyl-anilinium nitrate. Acta Crystallogr Sect E Struct Rep Online. 2009;65:o2744doi: 10.1107/S1600536809041488.
Benali-Cherif, N., Boussekine, H., Boutobba, Z., & Dadda, N. (2009). 4-Methyl-anilinium nitrate. Acta crystallographica. Section E, Structure reports online, 65o2744. https://doi.org/10.1107/S1600536809041488
Benali-Cherif, Nourredine, et al. "4-Methyl-anilinium nitrate." Acta crystallographica. Section E, Structure reports online vol. 65 (2009): o2744. doi: https://doi.org/10.1107/S1600536809041488
Benali-Cherif N, Boussekine H, Boutobba Z, Dadda N. 4-Methyl-anilinium nitrate. Acta Crystallogr Sect E Struct Rep Online. 2009 Oct 17;65:o2744. doi: 10.1107/S1600536809041488. PMID: 21578339; PMCID: PMC2971342.
Copy Download .nbib Format: NLM
Hydrogen bonding in cytosinium dihydrogen phosphite.

Acta crystallographica. Section E, Structure reports online

Messai A, Benali-Cherif N, Jeanneau E, Luneau D.
PMID: 21583952
Acta Crystallogr Sect E Struct Rep Online. 2009 Apr 30;65:o1147-8. doi: 10.1107/S1600536809014020.

In the title compound, C(4)H(8)N(3)O(4)P(+)·H(2)PO(3) (-), the cytosine mol-ecule is monoprotonated and the phospho-ric acid is in the monoionized state. Strong hydrogen bonds, dominated by N-H⋯O inter-actions, are responsible for cohesion between the organic and inorganic layers and maintain...

Cite
Messai A, Benali-Cherif N, Jeanneau E, et al. Hydrogen bonding in cytosinium dihydrogen phosphite. Acta Crystallogr Sect E Struct Rep Online. 2009;65:o1147-8doi: 10.1107/S1600536809014020.
Messai, A., Benali-Cherif, N., Jeanneau, E., & Luneau, D. (2009). Hydrogen bonding in cytosinium dihydrogen phosphite. Acta crystallographica. Section E, Structure reports online, 65o1147-8. https://doi.org/10.1107/S1600536809014020
Messai, Amel, et al. "Hydrogen bonding in cytosinium dihydrogen phosphite." Acta crystallographica. Section E, Structure reports online vol. 65 (2009): o1147-8. doi: https://doi.org/10.1107/S1600536809014020
Messai A, Benali-Cherif N, Jeanneau E, Luneau D. Hydrogen bonding in cytosinium dihydrogen phosphite. Acta Crystallogr Sect E Struct Rep Online. 2009 Apr 30;65:o1147-8. doi: 10.1107/S1600536809014020. PMID: 21583952; PMCID: PMC2977815.
Copy Download .nbib Format: NLM
trans-Diaqua-bis-(dl-valinato-κN,O)nickel(II).

Acta crystallographica. Section E, Structure reports online

Messai A, Benali-Cherif R, Jeanneau E, Benali-Cherif N.
PMID: 22065415
Acta Crystallogr Sect E Struct Rep Online. 2011 Sep 01;67:m1204. doi: 10.1107/S1600536811031072. Epub 2011 Aug 06.

In the title complex, [Ni(C(5)H(9)NO(2))(2)(H(2)O)(2)], the Ni(II) atom, located on a centre of inversion, is trans-coordinated by two O atoms and two N atoms from d-bidentate valine and l-bidentate valine ligands and two water O atoms in an octa-hedral...

Cite
Messai A, Benali-Cherif R, Jeanneau E, et al. trans-Diaqua-bis-(dl-valinato-κN,O)nickel(II). Acta Crystallogr Sect E Struct Rep Online. 2011;67:m1204doi: 10.1107/S1600536811031072.
Messai, A., Benali-Cherif, R., Jeanneau, E., & Benali-Cherif, N. (2011). trans-Diaqua-bis-(dl-valinato-κN,O)nickel(II). Acta crystallographica. Section E, Structure reports online, 67m1204. https://doi.org/10.1107/S1600536811031072
Messai, Amel, et al. "trans-Diaqua-bis-(dl-valinato-κN,O)nickel(II)." Acta crystallographica. Section E, Structure reports online vol. 67 (2011): m1204. doi: https://doi.org/10.1107/S1600536811031072
Messai A, Benali-Cherif R, Jeanneau E, Benali-Cherif N. trans-Diaqua-bis-(dl-valinato-κN,O)nickel(II). Acta Crystallogr Sect E Struct Rep Online. 2011 Sep 01;67:m1204. doi: 10.1107/S1600536811031072. Epub 2011 Aug 06. PMID: 22065415; PMCID: PMC3200705.
Copy Download .nbib Format: NLM
Licensing of γδT cells for professional antigen presentation: A new role for antibodies in regulation of antitumor immune responses.

Oncoimmunology

Anderson J, Gustafsson K, Himoudi N, Yan M, Heuijerjans J.
PMID: 23264926
Oncoimmunology. 2012 Dec 01;1(9):1652-1654. doi: 10.4161/onci.21971.

Following activation, γδ T cells display many properties of lymphocytes from the innate immune system, yet how they mediate antigen presentation remains an open conundrum. In humans, circulating γδ T cells that express the Vγ9Vδ2 T-cell receptor become reversibly...

Cite
Anderson J, Gustafsson K, Himoudi N, et al. Licensing of γδT cells for professional antigen presentation: A new role for antibodies in regulation of antitumor immune responses. Oncoimmunology. 2012;1(9):1652-1654doi: 10.4161/onci.21971.
Anderson, J., Gustafsson, K., Himoudi, N., Yan, M., & Heuijerjans, J. (2012). Licensing of γδT cells for professional antigen presentation: A new role for antibodies in regulation of antitumor immune responses. Oncoimmunology, 1(9), 1652-1654. https://doi.org/10.4161/onci.21971
Anderson, John, et al. "Licensing of γδT cells for professional antigen presentation: A new role for antibodies in regulation of antitumor immune responses." Oncoimmunology vol. 1,9 (2012): 1652-1654. doi: https://doi.org/10.4161/onci.21971
Anderson J, Gustafsson K, Himoudi N, Yan M, Heuijerjans J. Licensing of γδT cells for professional antigen presentation: A new role for antibodies in regulation of antitumor immune responses. Oncoimmunology. 2012 Dec 01;1(9):1652-1654. doi: 10.4161/onci.21971. PMID: 23264926; PMCID: PMC3525635.
Copy Download .nbib Format: NLM
Strong angular momentum effects in near-barrier fusion reactions.

Physical review letters

Barrette J, Beck FA, Boek E, Byrski T, Duchne G, Dudek J, Gehringer C, Haas B, Keinonen J, Merdinger JC, Nazarewicz W, Nourredine A, Rauch V, Styczen J, Tobbeche S, Vivien JP.
PMID: 10031505
Phys Rev Lett. 1985 Feb 04;54(5):398-401. doi: 10.1103/PhysRevLett.54.398.

No abstract available.

Cite
Barrette J, Beck FA, Boek E, et al. Strong angular momentum effects in near-barrier fusion reactions. Phys Rev Lett. 1985;54(5):398-401doi: 10.1103/PhysRevLett.54.398.
Barrette, J., Beck, F. A., Boek, E., Byrski, T., Duchne, G., Dudek, J., Gehringer, C., Haas, B., Keinonen, J., Merdinger, J. C., Nazarewicz, W., Nourredine, A., Rauch, V., Styczen, J., Tobbeche, S., & Vivien, J. P. (1985). Strong angular momentum effects in near-barrier fusion reactions. Physical review letters, 54(5), 398-401. https://doi.org/10.1103/PhysRevLett.54.398
Barrette, et al. "Strong angular momentum effects in near-barrier fusion reactions." Physical review letters vol. 54,5 (1985): 398-401. doi: https://doi.org/10.1103/PhysRevLett.54.398
Barrette J, Beck FA, Boek E, Byrski T, Duchne G, Dudek J, Gehringer C, Haas B, Keinonen J, Merdinger JC, Nazarewicz W, Nourredine A, Rauch V, Styczen J, Tobbeche S, Vivien JP. Strong angular momentum effects in near-barrier fusion reactions. Phys Rev Lett. 1985 Feb 04;54(5):398-401. doi: 10.1103/PhysRevLett.54.398. PMID: 10031505.
Copy Download .nbib Format: NLM
Risk Assessment of Histamine in Chilled, Frozen, Canned and Semi-Preserved Fish in Morocco; Implementation of Risk Ranger and Recommendations to Risk Managers.

Foods (Basel, Switzerland)

Hariri OE, Bouchriti N, Bengueddour R.
PMID: 30257518
Foods. 2018 Sep 25;7(10). doi: 10.3390/foods7100157.

A risk assessment of histamine was conducted for different categories of fishery products in the market. Risk estimates were assessed using the Risk Ranger tool. The estimated risks associated with the consumption of canned, semi-preserved and frozen fish are...

Cite
Hariri OE, Bouchriti N, Bengueddour R. Risk Assessment of Histamine in Chilled, Frozen, Canned and Semi-Preserved Fish in Morocco; Implementation of Risk Ranger and Recommendations to Risk Managers. Foods. 2018;7(10)doi: 10.3390/foods7100157.
Hariri, O. E., Bouchriti, N., & Bengueddour, R. (2018). Risk Assessment of Histamine in Chilled, Frozen, Canned and Semi-Preserved Fish in Morocco; Implementation of Risk Ranger and Recommendations to Risk Managers. Foods (Basel, Switzerland), 7(10), . https://doi.org/10.3390/foods7100157
Hariri, Oleya El, et al. "Risk Assessment of Histamine in Chilled, Frozen, Canned and Semi-Preserved Fish in Morocco; Implementation of Risk Ranger and Recommendations to Risk Managers." Foods (Basel, Switzerland) vol. 7,10 (2018). doi: https://doi.org/10.3390/foods7100157
Hariri OE, Bouchriti N, Bengueddour R. Risk Assessment of Histamine in Chilled, Frozen, Canned and Semi-Preserved Fish in Morocco; Implementation of Risk Ranger and Recommendations to Risk Managers. Foods. 2018 Sep 25;7(10). doi: 10.3390/foods7100157. PMID: 30257518; PMCID: PMC6210130.
Copy Download .nbib Format: NLM
Comparison of Clinical Features and Outcomes Between Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma in the United States.

Hepatology (Baltimore, Md.)

Lee YT, Wang JJ, Luu M, Noureddin M, Nissen NN, Patel TC, Roberts LR, Singal AG, Gores GJ, Yang JD.
PMID: 34114675
Hepatology. 2021 Nov;74(5):2622-2632. doi: 10.1002/hep.32007. Epub 2021 Sep 25.

BACKGROUND AND AIMS: Intrahepatic cholangiocarcinoma (iCCA) and hepatocellular carcinoma (HCC) are the most common primary liver cancers (PLCs). Differences in their clinical features and outcomes are open for investigation in a large-scale study. We aim to investigate the differences...

Cite
Lee YT, Wang JJ, Luu M, et al. Comparison of Clinical Features and Outcomes Between Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma in the United States. Hepatology. 2021;74(5):2622-2632doi: 10.1002/hep.32007.
Lee, Y. T., Wang, J. J., Luu, M., Noureddin, M., Nissen, N. N., Patel, T. C., Roberts, L. R., Singal, A. G., Gores, G. J., & Yang, J. D. (2021). Comparison of Clinical Features and Outcomes Between Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma in the United States. Hepatology (Baltimore, Md.), 74(5), 2622-2632. https://doi.org/10.1002/hep.32007
Lee, Yi-Te, et al. "Comparison of Clinical Features and Outcomes Between Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma in the United States." Hepatology (Baltimore, Md.) vol. 74,5 (2021): 2622-2632. doi: https://doi.org/10.1002/hep.32007
Lee YT, Wang JJ, Luu M, Noureddin M, Nissen NN, Patel TC, Roberts LR, Singal AG, Gores GJ, Yang JD. Comparison of Clinical Features and Outcomes Between Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma in the United States. Hepatology. 2021 Nov;74(5):2622-2632. doi: 10.1002/hep.32007. Epub 2021 Sep 25. PMID: 34114675.
Copy Download .nbib Format: NLM
Duodenal Microbiome and Serum Metabolites Predict Hepatocellular Carcinoma in a Multicenter Cohort of Patients with Cirrhosis.

Digestive diseases and sciences

Dong TS, Jacobs JP, Agopian V, Pisegna JR, Ayoub W, Durazo F, Enayati P, Sundaram V, Benhammou JN, Noureddin M, Choi G, Lagishetty V, Fiehn O, Goodman MT, Elashoff D, Hussain SK.
PMID: 34799768
Dig Dis Sci. 2021 Nov 20; doi: 10.1007/s10620-021-07299-2. Epub 2021 Nov 20.

BACKGROUND: Hepatocellular carcinoma (HCC) is rapidly increasing in the U.S. and is a leading cause of mortality for patients with cirrhosis. Discovering novel biomarkers for risk stratification of HCC is paramount. We examined biomarkers of the gut-liver axis in...

Cite
Dong TS, Jacobs JP, Agopian V, et al. Duodenal Microbiome and Serum Metabolites Predict Hepatocellular Carcinoma in a Multicenter Cohort of Patients with Cirrhosis. Dig Dis Sci. 2021;doi: 10.1007/s10620-021-07299-2.
Dong, T. S., Jacobs, J. P., Agopian, V., Pisegna, J. R., Ayoub, W., Durazo, F., Enayati, P., Sundaram, V., Benhammou, J. N., Noureddin, M., Choi, G., Lagishetty, V., Fiehn, O., Goodman, M. T., Elashoff, D., & Hussain, S. K. (2021). Duodenal Microbiome and Serum Metabolites Predict Hepatocellular Carcinoma in a Multicenter Cohort of Patients with Cirrhosis. Digestive diseases and sciences, . https://doi.org/10.1007/s10620-021-07299-2
Dong, Tien S, et al. "Duodenal Microbiome and Serum Metabolites Predict Hepatocellular Carcinoma in a Multicenter Cohort of Patients with Cirrhosis." Digestive diseases and sciences vol. (2021). doi: https://doi.org/10.1007/s10620-021-07299-2
Dong TS, Jacobs JP, Agopian V, Pisegna JR, Ayoub W, Durazo F, Enayati P, Sundaram V, Benhammou JN, Noureddin M, Choi G, Lagishetty V, Fiehn O, Goodman MT, Elashoff D, Hussain SK. Duodenal Microbiome and Serum Metabolites Predict Hepatocellular Carcinoma in a Multicenter Cohort of Patients with Cirrhosis. Dig Dis Sci. 2021 Nov 20; doi: 10.1007/s10620-021-07299-2. Epub 2021 Nov 20. PMID: 34799768.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 119 entries